Tech Company Financing Transactions
Kereos Funding Round
Kereos, based in Saint Louis, raised $6.6 million from Advantage Capital Partners, Prolog Ventures and RiverVest Venture Partners.
Transaction Overview
Company Name
Announced On
3/31/2007
Transaction Type
Venture Equity
Amount
$6,600,000
Round
Undisclosed
Investors
Prolog Ventures (Gregory Johnson)
RiverVest Venture Partners (Thomas Melzer)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4041 Forest Park Ave.
Saint Louis, MO 63108
USA
Saint Louis, MO 63108
USA
Phone
Website
Email Address
Overview
Kereos, a biotechnology company developing targeted imaging agents and therapeutics to improve the detection and treatment of cancer and cardiovascular disease,
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Executive Vice President
John Hefti
VP - Manufacturing
Kendall Killgore
Browse more venture capital transactions:
Prev: 3/31/2007: ChoiceStream venture capital transaction
Next: 3/31/2007: Streaming 21 venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs